TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest announcement is out from Icecure Medical ( (ICCM) ).
On December 5, 2025, IceCure Medical announced it received a Notice of Allowance for a patent in China for its Cryogen Flow Control, enhancing the efficacy and precision of its cryoablation procedures. This development strengthens IceCure’s intellectual property portfolio, which now includes 55 patents worldwide, and supports its strategic positioning as a leader in cryoablation technology, particularly following the FDA marketing authorization for its ProSense® system in treating low-risk breast cancer.
The most recent analyst rating on (ICCM) stock is a Hold with a $0.70 price target. To see the full list of analyst forecasts on Icecure Medical stock, see the ICCM Stock Forecast page.
Spark’s Take on ICCM Stock
According to Spark, TipRanks’ AI Analyst, ICCM is a Neutral.
Icecure Medical’s overall stock score is primarily impacted by its challenging financial performance, with persistent losses and negative cash flows. The technical analysis indicates a bearish trend, and valuation metrics are weak due to unprofitability. However, the positive sentiment from the earnings call, driven by FDA approval and strategic market opportunities, provides some optimism for future growth.
To see Spark’s full report on ICCM stock, click here.
More about Icecure Medical
IceCure Medical Ltd. is a company specializing in the development and marketing of advanced cryoablation therapy systems, which utilize liquid nitrogen to destroy tumors by freezing. The company’s primary focus areas include breast, kidney, bone, and lung cancer, offering a minimally invasive alternative to surgical tumor removal. IceCure’s flagship product, the ProSense® system, is marketed globally and has received regulatory approvals in the U.S., Europe, and Asia.
Average Trading Volume: 1,185,216
Technical Sentiment Signal: Sell
Current Market Cap: $46.64M
For an in-depth examination of ICCM stock, go to TipRanks’ Overview page.